Smoking during pregnancy presents health risks for both the mother and her child. In this study we followed changes in the production of steroid hormones in pregnant smokers. We focused on changes in steroidogenesis in the blood of mothers in their 37 th week of pregnancy and in mixed cord blood from their newborns. The study included 88 healthy women with physiological pregnancies (17 active smokers and 71 nonsmokers). We separately analyzed hormonal changes associated with smoking according to the sex of newborns. In women with male fetuses, we found higher levels of serum cortisone, dehydroepiandrosterone (DHEA), 7α-OH-DHEA, 17-OH pregnenolone, testosterone, and androstenedione in smokers at the 37 th week compared to non-smokers. In women with female fetuses, we found lower serum levels of 7β-OH-DHEA and higher androstenedione in smokers at the 37 th week. We found significantly higher levels of testosterone in newborn males of smokers and higher levels of 7α-OH-DHEA in female newborns of smokers. Smoking during pregnancy induces changes in the production of steroids in both the mother and her child. These changes are different for different fetal sexes, with more pronounced changes in mothers carrying male newborns as well as in the newborn males themselves.
Introduction
Smoking during pregnancy endangers the health of the mother as well as the organism of the developing child. Smoking by women during pregnancy is a serious risk factor for a wide range of developmental health complications. In 2012, an analysis of data from 2000-2009 from the National Register of Mothers at Childbirth and the National Register of Newborns from the Institute of Health Information and Statistics of the Czech Republic was published. This analysis was focused on the use of alcohol, tobacco and illegal drugs in women who were hospitalized due to complications related to birth or in the newborn child. During that period 60,502 women were registered smokers from a total of 1,008,821 mothers. This means that about 6.5 % of women admitted to smoking at the end of pregnancy (Nechanská et al. 2012) . This data is likely to be markedly influenced by the fact that many women did not admit to smoking during pregnancy.
According to longitudinal studies, the consequences of smoking during pregnancy include the risk of premature labor being increased by 23 %, and medically indicated prematurely induced labor increased by 28 %. Medically indicated prematurely induced labor has been associated with the non-desirable side-effects of smoking during pregnancy (Montgomery and Ekbom 2002) . Children of smokers have more frequent congenital developmental disorders. Increased risks of malformed extremities, congenital heart defects, malformations of the urogenital system, and cleft lips and palates have also been reported. Newborns of mothers who smoked during pregnancy have on average lower S376 Adamcová et al. Vol. 66 birth weights than newborns of non-smokers, with a direct relationship to the number of cigarettes smoked (Cressman et al. 2012) .
Smoking during pregnancy significantly influences the production of many fetal hormones. Studies have described a higher production of ACTH and cortisol, with cortisol levels in children of smoking mothers positively correlated with the number of cigarettes smoked (Vavrarigou et al. 2006 ). Children of smokers have a lowered catecholamine reaction to hypoxia and stress during birth. This decreased reactivity of the adrenergic system could be related to the increase of Sudden Infant Death Syndrome (SIDS) in children of smoking mothers (Divers et al. 1981) . There is a 2.5-3 times higher risk of SIDS in children of smokers than in children of women who did not smoke during pregnancy (Somm et al. 2008) .
Children that have been exposed to smoking during prenatal development have more frequent cognitive function defects, behavioral disorders, attention problems, hyperactivity, psychological problems, and a higher tendency to become addicted. These disorders can last until puberty, adolescence, and even young adulthood. Epidemiological studies have shown that the higher incidence of these disorders in such prenatally exposed children and adults persist even after controlling for interfering factors. In addition, there are also direct correlations to the number of cigarettes smoked (Kukla et al. 2008) . It has been shown that expectant mothers who smoke during pregnancy have not just more frequent effects on the fetus/child, but also various later effects that may be manifested in adulthood as a result of defective fetal programming of the exposed individual (Dušková et al. 2014) . In particular, the production of steroid hormones, which have both genomic and neuroactive activity, may be one of the links between the effects of smoking during pregnancy and the later effects on the child as part of a wide spectrum of behavioral problems.
In physiological pregnancies, there are differences in the levels of steroid hormones in the pregnant woman depending on the sex of the fetus, and there are differences in the steroids of newborns depending on its sex, though the data from the literature are not consistent (Kuijper et al. 2013) . At the same time, changes in the production of steroid hormones induced by smoking are different for women and men (Dušková et al. 2012 , Jandíková et al. 2015 , Jandíková et al. 2017 , and this has been demonstrated in experimental models of prenatal nicotine exposure (Cross et al. 2016) . This highlights the necessity for analyzing changes in smoking women during pregnancy separately depending on the sex of her child. The aim of this study was to follow changes in the production of steroid hormones caused by smoking during pregnancy. We focused on changes in steroidogenesis in the blood of mothers in the 37 th week of pregnancy and in mixed cord blood from the newborn.
Methods
Our study included a total of 88 healthy pregnant women with a physiological course of gravidity, of which 17 were active smokers and 71 non-smokers. All women were of Czech nationality and gave birth spontaneously. Ex-smokers and passive smokers were excluded from the study. Other exclusion criteria were another addiction in their history, the use of medicines affecting steroidogenesis, gestational diabetes, hypertension, thyropathy, complications of pregnancy (hyperemesis, bleeding, uterine inflammation, or the risk of premature birth), intrauterine growth restriction, and cesarean section. Only singleton pregnancies were included. All participants signed informed consent and were informed about the study aims. The study was approved by the Ethical Commission of the General Faculty Hospital (protocol number 114/15).
Women were examined during the 37 th week of pregnancy, when they filled out an anonymous standardized questionnaire on their age, height, weight, gravidity/parity, complications during pregnancy, socioeconomic status, smoking history, knowledge on the dangers of smoking during pregnancy, and addiction to nicotine. The sex of the child was noted at birth.
Samples of venous blood from the mothers were taken from the cubital vein between 8:00 and 10:00 o'clock, during the 37 th week of pregnancy. At birth, a sample of mixed cord blood was taken. Blood samples were taken into Vacuette tubes (plastic tubes for sampling coagulating blood with a coagulation activator and separation gel). Serum was obtained by centrifugation for 5 min at 2000g at 4 °C, and then stored at -20 °C.
Selected steroid hormones (cortisol, cortisone, dehydroepiandrosterone (DHEA), 7α-hydroxy-dehydroepiandrosterone (7α-OH-DHEA), 7β-hydroxy-dehydroepiandrosterone (7β-OH-DHEA), 7-oxo-dehydroepiandrosterone (7-oxo-DHEA), pregnenolone, 17α-hydroxy-pregnenolone (17-OH-pregnenolone), testosterone, androstenedione, progesterone, 17-OHprogesterone, corticosterone, estrone (E1), estradiol (E2), and estriol (E3)) were measured by LC-MS/MS using methods described elsewhere (Sosvorová et al. 2015a ,b, Vítků et al. 2015 , Vítků et al. 2016 .
Statistical analysis
Data were transformed by Box-Cox transformation before further processing due to the non-Gaussian distribution and non-constant variance (heteroscedasticity) of all variables. Subsequently, Student´s t-test was used for comparison of steroid levels between smokers and non-smokers. The statistical software Statgraphics Centurion, version XVI from Statpoint Inc. (Warrenton, VA, USA) was used for all data transformations and ANOVA analyses.
Results
As shown in Table 1 , smokers and non-smokers did not differ in age. Smokers had a higher weight gain during pregnancy of an average of 4 kg. In contrast, the birth weights of the children of smokers were lower by an average of 300 g. The women were divided according to the sex of the newborn child, and hormonal changes in relationship to smoking were analyzed separately. Data are means ± SD.
In the group of women who were carrying a male fetus, the women who smoked had significantly higher levels of cortisone, DHEA, 7α-OH-DHEA, 17-OH-pregnenolone, testosterone and androstenedione at the 37 th week. Other measured steroids (cortisol, 7β-OH-DHEA, 7-oxo-DHEA, pregnenolone, progesterone, 17-OH-progesterone, corticosterone, E1, E2, E3) did not differ between smokers and non-smokers ( Fig. 1) .
In the group of women who were carrying a female fetus, the women who smoked had significantly lower levels of 7β-OH-DHEA and higher levels of androstenedione at the 37 th week. In addition, smokers had borderline lower levels of E3, though not statistically significant. Other measured steroids (cortisol, cortisone, DHEA, 7β-OH-DHEA, 7-oxo-DHEA, pregnenolone, 17-OH-progesterone, testosterone, progesterone, 17-OHprogesterone, corticosterone, E1, E2) did not differ for smokers, though they had much higher ranges of values than did non-smokers (Fig. 2) .
In newborn males, we found significantly higher levels of testosterone in the children of smokers than for children of non-smokers. Other measured steroids had higher ranges of values in the children of smokers, but the changes were not significant ( Fig. 3) . For newborn females, we found significantly higher 7α-OH-DHEA.
Other measured hormones showed no significant changes, though again the children of smokers had a higher range of values (Fig. 4) .
S378 Adamcová et al. Vol. 66 Fig. 1 . The comparison of steroid levels in maternal blood between smoking and non-smoking pregnant women in 37 th week, who were carrying a male fetus. In women smokers, significantly higher levels of cortisone, DHEA, 7α-OH-DHEA, 17-OH-pregnenolone, testosterone and androstenedione were found. Other tested steroids did not differ between smokers and non-smokers. Error bars represent group means with their 95 % confidence intervals; statistical significance (p-value) is shown in each graph. . 2 . The comparison of steroid levels in maternal blood between smoking and non-smoking pregnant women in 37 th week, who were carrying a female fetus. In women smokers, significantly lower levels of 7β-OH-DHEA and higher levels of androstenedione were observed. In addition, female smokers had lower estriol, though not statistically significant. Other tested steroids were not different for smokers, but the ranges of values were much greater than for non-smokers. Error bars represent group means with their 95 % confidence intervals; statistical significance (p-value) is shown in each graph. Fig. 3 . The comparison of steroid levels in mixture cord blood between male newborn of smoking and non-smoking mothers. In male newborns of smoking mothers, significantly higher levels of testosterone compared to males from non-smokers were found. Other tested steroids had higher range of values in newborns of smokers, but not statistically significant. Error bars represent group means with their 95 % confidence intervals; statistical significance (p-value) is shown in each graph. Fig. 4 . The comparison of steroid levels in mixture cord blood between female newborn of smoking and non-smoking mothers. In female newborns of smoking mothers, significantly higher levels of 7α-OH-DHEA were observed. Other tested hormones showed non-significant differences, though again newborns of smokers had a higher range of values. Error bars represent group means with their 95 % confidence intervals; statistical significance (p-value) is shown in each graph. S382 Adamcová et al.
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Discussion
Smoking of women during pregnancy presents a serious health risk for both the mother and her child, with increased risks of perinatological complications and of developing various disorders later in life. From the point of view of the mother, the increased gain in weight during pregnancy is noteworthy. Our results are in agreement with the study of Rode et al. (2013) , which followed changes in weight during pregnancy in 1774 women. They found that women quitting smoking during pregnancy had a higher weight gain than non-smokers, and proposed two possible reasons. First, the absence of nicotine itself, which lowers the rate of stomach emptying, quickens intestinal peristalsis, and increases basal metabolism. Second, women who quit smoking tend to use food that is often high in sugar and fats as a substitute for the positive feelings associated with smoking a cigarette. The average weight gain in women quitting smoking was 2 kg more than for non-smokers (Rode et al. 2013) . We found that women smokers gained an average of 4 kg more than non-smokers. This could be caused by the fact that most of them reduced the number of cigarettes smoked after finding out they were pregnant, from an average of 21 to 6 cigarettes daily, and thus may have experienced symptoms of abstinence including an increased desire for food.
In addition to the generally well-known effects such as lower newborn birth weights (Ingvarsson et al. 2007) , and which we also found in our study, smoking during pregnancy has been found to affect hormonal homeostasis in both the mother and child. When studying the effects of maternal smoking on fetal steroidogenesis and its possible consequences, it is necessary to first take into account the specifics of steroid production and function during pregnancy.
During pregnancy, the production of estrogens (E2 and E1) increases 100-fold, while the production of E3, the main estrogen of pregnancy, increases many times more. Outside of pregnancy, E3 is almost absent in the human organisms. This increase in estrogen concentrations in the maternal blood circulation is dependent on the function of the fetal-placental unit. Dehydroepiandrosterone sulfate (DHEAS) from the fetal adrenal gland is converted to 16α-hydroxylase in the fetal liver as a precursor for E3. Shortly after delivery of the child, this activity ceases (Kuijper et al. 2013) . In pregnant women, the production of DHEAS increases while serum concentrations are lower than in fertile women outside of pregnancy, likely because of its conversion to estrogens (Tawaga et al. 2004) . Androstenedione is an androgen that is a precursor for the production of testosterone and estrogens (E1 and E2). The enzyme 17β-hydroxysteroid dehydrogenase changes androstenedione into testosterone, which is then aromatized into estrogens. Placental aromatization is so efficient that any androgens that enter the placenta from the fetus are modified into estrogens. This is crucial for twins of different sexes, to ensure that the female fetus is not influenced by the androgens of her brother, not just for gonadal development but also to prevent male-type behavior (Kuijper et al. 2015) . The development of the brain and its sexual differentiation is dependent on steroids produced in the gonads of the fetus. A key part of this is protection of the brain from the excess estrogens that are typical during pregnancy. The developing brain is protected from estrogens by alpha-fetoproteins, which prevent estrogens from entering nerve cells. In males fetuses testosterone produced in the fetal gonads enters the cellular cytoplasm, where it is aromatized into E2 that binds to estrogen receptors of the cell nucleus and is responsible for the development of the male brain (McCarthy 2007) . This only happens during the individual's intrauterine period. The specific role of steroids during pregnancy is therefore necessary to consider when evaluating the effects of changes in steroidogenesis induced by smoking, because modifying just one enzyme or steroid levels in just one compartment can lead to changes in all others and affect multiple processes in the developing fetus and its future programming. It is therefore difficult to extrapolate from changes in several steroids to changes overall, but such changes can provide signals that bring attention to such changes and give us information that may help explain those changes described in the children of smokers.
Changes in estrogen due to smoking during pregnancy have been the focus of many studies. Lower levels of E2 have been found in pregnant smokers (Andersen et al. 1984) and in newborns of smoking mothers (Andersen et al. 1984 , Varvarigou et al. 2009 ). In our study, we found only non-significantly lower E3 levels in smokers at the 37 th week of pregnancy who were carrying female fetuses.
The influence of maternal smoking on male children has also been the subject of many studies, often in association with defects in adult reproductive function. This has been demonstrated in animal models, though not yet in humans (Ratcliffe et al. 1992) . Another study that also failed to find an influence on fertility did find, however, a higher ratio of free testosterone to free E2 in the children of smokers. Those data may indicate a shift in the hypothalamic-pituitary-gonadal axis in relation to higher androgenicity (Remlau-Hansen et al. 2008) . In line with these results, we found higher levels of testosterone in newborn males of mothers who smoked.
In animal models, higher levels of free testosterone have been found in adult males exposed to the effects of nicotine during their intrauterine life (Smith et al. 2003) . There is also data in the literature on testosterone levels in smokers who are pregnant and relationships to smoking in their adult offspring. One interesting finding is the relationship between higher testosterone levels in smoking mothers and smoking in their daughters. Higher testosterone levels in women who smoked during pregnancy correlated with smoking in their daughters, while prenatal cotinine levels were not correlated. Testosterone levels in smoking mothers thus seem to be a risk factor for smoking in their daughters (Kandel et al. 1999) . However, these findings were not supported by the study of Stround et al. (2014) , which did not find an association with maternal testosterone levels in the third trimester and smoking addition in their adult daughters, but did find a relationship with maternal cortisol in the third trimester. That study also failed to find associations of maternal smoking with either testosterone or cortisol in male offspring. In our study, we found no evidence of changes in testosterone in the newborn girls of mothers who smoked or in the mothers who were carrying female children. However, we did find a higher range of testosterone values, with some levels being very increased. On the other hand, we did find significantly higher levels of androstenedione in women smokers in the 37 th week of pregnancy, who carried female fetuses. Many studies using experimental models have found long-term effects of prenatal exposure to nicotine, but only few have tracked differences in light of the sex of the offspring. Even though it has been shown that while prenatal exposure to nicotine induces a range of changes to the structure and function of the child's brain, male offspring suffer even more undesirably side effects to cholinergic, serotonin and β2-adrenergic functioning. Exposure to nicotine in utero in male offspring increases the future risk of nicotine addiction, but not in female offspring. Prenatal exposure to nicotine in rodent experimental models increased corticosterone levels by directly affecting the adrenal cortex, which led to significantly higher testosterone levels in the perinatal period (Cross et al. 2016) . Our study also found changes in pregnant women smokers who were carrying male children, and in newborn males we found higher testosterone levels. This is in line with the data from experimental models, and indicates that male fetuses are more sensitive to changes induced by smoking.
In smoking mothers with male children we found higher levels of the adrenal steroids cortisone, DHEA, 7α-OH-DHEA, and 17α-OH-pregnenolone compared to non-smokers. In contrast, smoking mothers with female children had significantly lower 7β-OH-DHEA of adrenal origin compared to non-smokers, a steroid that is considered to have marked influence on the immune system. Signs of lower E3 levels are also in agreement with the hypothesis that smoking has an undesirable influence on adrenal steroidogenesis, since E3 is produced in the placenta mostly from products of the fetal adrenal glands.
There is data in the literature about changes to the hypothalamic-pituitary-adrenal axis in the children of women who smoked during pregnancy. However, results of studies that followed cortisol are inconsistent, with some finding similar levels and others finding higher. McDonald et al. (2006) measured ACTH and cortisol levels in the cord blood of newborns from planned cesarean sections, and found that in children of smokers ACTH was higher but cortisol was the same. Similar results were found by Sybulski et al. (1977) . However, many other studies have found higher cortisol levels in children of smokers (Lieberman et al. 1992 , Vavrarigou et al. 2006 , Vavrarigou et al. 2009 ). Vavrarigou et al. (2006 found higher cortisol both in the children of smokers delivered by cesarean section and those delivered vaginally. Cortisol levels in children of smokers born by cesarean section positively correlated with the number of cigarettes smoked by their mothers. In our study, we found higher cortisol levels in the 37 th week only in pregnant smokers who carried male fetuses. We found no changes in newborns, but both cortisol and cortisone had much higher ranges of values in both male and female children of smoking mothers compared to children of non-smokers. This could reflect differences in the effects on steroids in individual children of smokers, and may partially explain the inconsistent data in the literature.
Longitudinal studies following changes to the hypothalamic-pituitary-adrenal axis after prenatal exposure to smoking are particularly interesting. Saridjan et al. (2010) measured the diurnal cortisol profiles of Vol. 66 children from 12 and 20 months, and found that the children of smokers had a positive cortisol reaction after awaking. The study of Scheutze et al. (2008) analyzed the cortisol reaction to stress in seven-month-old children, and found higher levels in those whose mothers smoked during pregnancy. In addition, they found a difference in the reactivity for different sexes, with exposed boys having a higher cortisol reaction than exposed girls. These studies show that prenatal exposure to smoking can influence the programming of the hypothalamic-pituitaryadrenal axis. We did not find sex-related differences in cortisol or differences in the reaction to the stress of birth in newborns.
In general, smoking during pregnancy induces changes in the production of steroids in both the pregnant women and their children. These changes are different for different sexes of fetus, with more marked changes in smokers who are carrying boys as well as in the newborn boys themselves. However, the results of our study are limited by the smaller number of smokers versus controls.
